Question 1

How many shares of SLNO does BlackRock, Inc. own?

Accepted Answer

BlackRock, Inc. previously held 0 shares of SLNO (SOLENO THERAPEUTICS INC) before exiting the position in 2026-Q2.

Question 2

What is BlackRock, Inc.'s SLNO position worth?

Accepted Answer

BlackRock, Inc.'s SLNO position was last reported at $0 in 2026-Q2 before the exit.

Question 3

Is BlackRock, Inc. buying or selling SLNO?

Accepted Answer

In 2026-Q2, BlackRock, Inc. exited their SLNO position entirely (-100.0% change in shares).

Question 4

When did BlackRock, Inc. first buy SLNO?

Accepted Answer

Based on available 13F filings, BlackRock, Inc. first reported a position in SLNO in 2024-Q4. They have held the position across 7 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Exited	0	-100.0%	$0	0.0%	$53.01	0
2026-Q1	Decreased	3.7M	-3.3%	$125.3M	0.0%	$37.72	0
2025-Q4	Increased	3.9M	+10.9%	$179.3M	0.0%	$46.29	34
2025-Q3	Increased	3.5M	+22.8%	$236.1M	0.0%	$68.16	37
2025-Q2	Increased	2.8M	+48.7%	$238.3M	0.0%	$83.25	42
2025-Q1	Decreased	1.9M	-4.8%	$136.7M	0.0%	$71.99	0
2024-Q4	New	2M	-	$90.3M	0.0%	$45.30	41

SLNO7 quarters

SLNO
7 quarters